Walgreens Boots Alliance Stock Price, News & Analysis (NASDAQ:WBA)

$71.25 -0.05 (-0.07 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$71.30
Today's Range$71.00 - $71.98
52-Week Range$63.82 - $88.00
Volume6.23 million shs
Average Volume5.37 million shs
Market Capitalization$71.98 billion
P/E Ratio13.84
Dividend Yield2.28%
Beta1.2

About Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance logoWalgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.


Industry, Sector and Symbol:
  • Industry: Drug Retailers
  • Sub-Industry: Drug Retail
  • Sector: Drug Retailers - NEC
  • Symbol: NASDAQ:WBA
  • CUSIP: 93142210
  • Web: www.walgreensbootsalliance.com
Debt:
  • Debt-to-Equity Ratio: 0.45%
  • Current Ratio: 1.07%
  • Quick Ratio: 0.59%
Price-To-Earnings:
  • Trailing P/E Ratio: 13.84
  • Forward P/E Ratio: 12.84
  • P/E Growth: 1.26
Sales & Book Value:
  • Annual Sales: $118.214 billion
  • Price / Sales: 0.61
  • Cash Flow: $6.75 per share
  • Price / Cash: 10.55
  • Book Value: $26.42 per share
  • Price / Book: 2.70
Dividend:
  • Annual Dividend: $1.60
  • Dividend Yield: 2.3%
Profitability:
  • Trailing EPS: $3.78
  • Net Income: $4.078 billion
  • Net Margins: 3.45%
  • Return on Equity: 18.36%
  • Return on Assets: 7.73%
Misc:
  • Employees: 345,000
  • Outstanding Shares: 1,009,550,000
 

Frequently Asked Questions for Walgreens Boots Alliance (NASDAQ:WBA)

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance declared a quarterly dividend on Wednesday, October 25th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share on Tuesday, December 12th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Friday, November 10th. View Walgreens Boots Alliance's Dividend History.

How will Walgreens Boots Alliance's stock buyback program work?

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase program on Thursday, October 26th 2017, which allows the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its quarterly earnings data on Wednesday, October, 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.10. The pharmacy operator earned $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business's revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.07 EPS. View Walgreens Boots Alliance's Earnings History.

When will Walgreens Boots Alliance make its next earnings announcement?

Walgreens Boots Alliance is scheduled to release their next quarterly earnings announcement on Wednesday, January, 3rd 2018. View Earnings Estimates for Walgreens Boots Alliance.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance issued an update on its FY18 earnings guidance on Wednesday, October, 25th. The company provided earnings per share guidance of $5.40-5.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.47.

Where is Walgreens Boots Alliance's stock going? Where will Walgreens Boots Alliance's stock price be in 2017?

20 brokers have issued 12-month price targets for Walgreens Boots Alliance's shares. Their forecasts range from $72.00 to $100.00. On average, they expect Walgreens Boots Alliance's stock price to reach $87.17 in the next year. View Analyst Ratings for Walgreens Boots Alliance.

What are Wall Street analysts saying about Walgreens Boots Alliance stock?

Here are some recent quotes from research analysts about Walgreens Boots Alliance stock:

  • 1. According to Zacks Investment Research, "Walgreens Boots’ fourth-quarter 2017 performance was quite promising, with revenues and earnings surpassing estimates. The company’s receipt of approval from the FTC for the modified deal involving the purchase of a limited number of Rite Aid store buoys optimism. Moreover, this merger is expected to extend Walgreens Boots’ growth strategy and offer operational benefits. We are also upbeat about Walgreens Boots’ ‘Next Chapter plan’ focused on a multi-faceted cost-reduction initiative through fiscal 2017. On the flip side, over the last six months, Walgreens Boots has been trading below the broader industry. Declining sales at the Retail Pharmacy International was a disappointment. The company faces tough competition along with currency fluctuations. Also, slowdown in generic introduction continues to weigh on margins." (10/30/2017)
  • 2. Pivotal Research analysts commented, "We believe that the asset based transaction with Rite Aid is much more beneficial for Walgreens Boots Alliance compared to the amended merger agreement from January 2017. Our quick read thru is that WBA is paying around $2.5 million per store compared to more than $4.1 million under the proposed transaction which would have included the divestiture of up to 1200 stores to Fred’s. Management appears to have a high level of confidence that it understands what is required from an FTC perspective and that the third attempt to consummate a deal with Rite Aid will pass regulatory scrutiny. The newly authorized share buyback program of $5 billion is also a significant positive for investors. The scaled down version transaction with Rite Aid will allow Walgreen to shrink the count at an accelerated rate through FY18. That said, we expect that core earnings will continue to be pressured. Quality of earnings was lacking of 3Q17, with a $0.07-$0.08 per share benefit from a lower than expected tax rate. Additionally, FIFO gross margin was down by 150 bps in the latest quarter on continued reimbursement pressures." (7/2/2017)
  • 3. Jefferies Group LLC analysts commented, "We believe that today’s announcement of the proposed divestiture of 865 RAD stores to FRED for $950MM in cash should be sufficient to appease regulatory competition concerns and eliminate concerns about WBA’s ability to close the RAD deal." (12/21/2016)

Who are some of Walgreens Boots Alliance's key competitors?

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the folowing people:

  • James A. Skinner, Executive Chairman of the Board (Age 72)
  • Stefano Pessina, Executive Vice Chairman and Chief Executive Officer (Age 76)
  • George R. Fairweather, Executive Vice President and Global Chief Financial Officer (Age 60)
  • Ornella Barra, Co-Chief Operating Officer (Age 63)
  • Alexander W. Gourlay, Co-Chief Operating Officer (Age 57)
  • Kathleen Wilson-Thompson, Executive Vice President, Global Chief Human Resources Officer (Age 60)
  • Marco Patrick Anthony Pagni, Executive Vice President, Global Chief Administrative Officer, General Counsel (Age 55)
  • Ken Murphy, Executive Vice President, Chief Commercial Officer, President of Global Brands (Age 51)
  • Kimberly R. Scardino, Senior Vice President, Chief Accounting Officer, Global Controller (Age 46)
  • William C. Foote, Lead Independent Director (Age 65)

Who owns Walgreens Boots Alliance stock?

Walgreens Boots Alliance's stock is owned by many different of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (1.17%), Nordea Investment Management AB (1.01%), Caisse DE Depot ET Placement DU Quebec (0.67%), Dimensional Fund Advisors LP (0.66%), CI Global Investments Inc. (0.55%) and Legal & General Group Plc (0.48%). Company insiders that own Walgreens Boots Alliance stock include Barry Rosenstein, George Rollo Fairweather, Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

Who sold Walgreens Boots Alliance stock? Who is selling Walgreens Boots Alliance stock?

Walgreens Boots Alliance's stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Bank of New York Mellon Corp, Prudential Financial Inc., Schroder Investment Management Group, APG Asset Management N.V., Mondrian Investment Partners LTD, Bessemer Group Inc. and CI Global Investments Inc.. Company insiders that have sold Walgreens Boots Alliance company stock in the last year include Kathleen Wilson-Thompson and William C Foote. View Insider Buying and Selling for Walgreens Boots Alliance.

Who bought Walgreens Boots Alliance stock? Who is buying Walgreens Boots Alliance stock?

Walgreens Boots Alliance's stock was purchased by a variety of institutional investors in the last quarter, including Harding Loevner LP, Dimensional Fund Advisors LP, Truepoint Inc., PGGM Investments, Vaughan David Investments Inc. IL, CI Investments Inc., Schwab Charles Investment Management Inc. and First Trust Advisors LP. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

How do I buy Walgreens Boots Alliance stock?

Shares of Walgreens Boots Alliance can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Walgreens Boots Alliance's stock price today?

One share of Walgreens Boots Alliance stock can currently be purchased for approximately $71.25.

How big of a company is Walgreens Boots Alliance?

Walgreens Boots Alliance has a market capitalization of $71.98 billion and generates $118.214 billion in revenue each year. The pharmacy operator earns $4.078 billion in net income (profit) each year or $3.78 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Rd, DEERFIELD, IL 60015-5145, United States. The pharmacy operator can be reached via phone at +1-847-3152500 or via email at [email protected]


MarketBeat Community Rating for Walgreens Boots Alliance (NASDAQ WBA)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  757 (Vote Outperform)
Underperform Votes:  580 (Vote Underperform)
Total Votes:  1,337
MarketBeat's community ratings are surveys of what our community members think about Walgreens Boots Alliance and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Walgreens Boots Alliance (NASDAQ:WBA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 7 Hold Ratings, 13 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $87.17 (22.34% upside)

Consensus Price Target History for Walgreens Boots Alliance (NASDAQ:WBA)

Price Target History for Walgreens Boots Alliance (NASDAQ:WBA)

Analysts' Ratings History for Walgreens Boots Alliance (NASDAQ:WBA)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/2/2017Citigroup Inc.Lower Price TargetBuy$95.00 -> $81.00N/AView Rating Details
11/1/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
10/29/2017Jefferies Group LLCSet Price TargetBuy$93.00N/AView Rating Details
10/26/2017Loop CapitalSet Price TargetBuy$95.00 -> $90.00N/AView Rating Details
10/25/2017Royal Bank Of CanadaReiterated RatingBuy$88.00N/AView Rating Details
10/24/2017MizuhoSet Price TargetBuy$94.00N/AView Rating Details
10/24/2017Pivotal ResearchLower Price TargetHold -> Hold$85.00 -> $73.00N/AView Rating Details
10/19/2017Robert W. BairdReiterated RatingOutperform$90.00 -> $80.00N/AView Rating Details
10/15/2017SunTrust Banks, Inc.Set Price TargetHold$72.00N/AView Rating Details
10/12/2017Needham & Company LLCReiterated RatingBuy$94.00N/AView Rating Details
10/6/2017Morgan StanleyDowngradeOverweight -> Equal Weight$95.00 -> $85.00N/AView Rating Details
9/27/2017Raymond James Financial, Inc.Reiterated RatingOutperform -> Market PerformLowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingBuy$97.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
6/28/2017Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral$89.00 -> $77.00LowView Rating Details
4/1/2017Barclays PLCSet Price TargetHold$79.00LowView Rating Details
3/22/2017Deutsche Bank AGReiterated RatingBuy$92.00LowView Rating Details
2/6/2017Atlantic SecuritiesUpgradeNeutral -> Overweight$95.00N/AView Rating Details
1/31/2017Evercore ISIReiterated RatingBuy$93.00N/AView Rating Details
1/31/2017Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
8/30/2016Bank of America CorporationReiterated RatingBuy$94.00N/AView Rating Details
7/22/2016Keefe, Bruyette & WoodsReiterated RatingMarket Perform -> UnderperformN/AView Rating Details
7/7/2016J P Morgan Chase & CoReiterated RatingBuyN/AView Rating Details
7/7/2016FBR & CoLower Price TargetMarket Perform$90.00 -> $85.00N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History and Estimates Chart for Walgreens Boots Alliance (NASDAQ:WBA)

Earnings by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Earnings History by Quarter for Walgreens Boots Alliance (NASDAQ WBA)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/3/2018$1.24N/AView Earnings Details
10/25/2017Q4 2017$1.21$1.31$29.93 billion$30.15 billionViewN/AView Earnings Details
6/29/2017Q3 2017$1.30$1.33$29.72 billion$30.12 billionViewN/AView Earnings Details
4/5/2017Q2 2017$1.36$1.36$30.17 billion$29.45 billionViewListenView Earnings Details
1/5/2017Q117$1.09$1.10$29.37 billion$28.50 billionViewListenView Earnings Details
10/20/2016Q416$0.99$1.07$29.06 billion$28.60 billionViewListenView Earnings Details
7/6/2016Q316$1.14$1.18$29.93 billion$29.50 billionViewN/AView Earnings Details
4/5/2016Q216$1.28$1.31$30.72 billion$30.18 billionViewN/AView Earnings Details
1/7/2016Q116$0.96$1.03$29.24 billion$29.00 billionViewN/AView Earnings Details
10/28/2015Q415$0.81$0.88$28.45 billion$28.50 billionViewListenView Earnings Details
7/9/2015Q315$0.87$1.02$30.28 billion$28.80 billionViewN/AView Earnings Details
4/9/2015Q215$0.94$1.18$27.27 billion$26.60 billionViewN/AView Earnings Details
12/23/2014Q115$0.75$0.81$19.43 billion$19.55 billionViewN/AView Earnings Details
9/30/2014Q414$0.74$0.74$19.02 billion$19.06 billionViewN/AView Earnings Details
6/24/2014Q314$0.94$0.91$19.33 billion$19.40 billionViewN/AView Earnings Details
3/25/2014Q214$0.93$0.91$19.61 billion$19.60 billionViewN/AView Earnings Details
12/20/2013Q1$0.72$0.72$17.98 billion$18.30 billionViewListenView Earnings Details
10/1/2013Q413$0.72$0.73$17.95 billion$17.90 billionViewN/AView Earnings Details
6/25/2013Q3 2013$0.91$0.85$18.44 billion$18.30 billionViewN/AView Earnings Details
3/19/2013Q2 2013$0.94$0.96$18.72 billion$18.65 billionViewN/AView Earnings Details
12/21/2012Q1 2013$0.70$0.58$17.50 billion$17.32 billionViewN/AView Earnings Details
9/28/2012Q412$0.56$0.63$17.16 billion$17.10 billionViewN/AView Earnings Details
6/19/2012$0.63$0.62ViewN/AView Earnings Details
3/27/2012$0.77$0.78ViewN/AView Earnings Details
12/21/2011$0.67$0.63ViewN/AView Earnings Details
9/27/2011$0.56$0.57ViewN/AView Earnings Details
6/21/2011$0.63$0.66ViewN/AView Earnings Details
3/22/2011$0.80$0.80ViewN/AView Earnings Details
12/22/2010$0.54$0.62$17.31 billion$17.34 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Walgreens Boots Alliance (NASDAQ:WBA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.44$1.44$1.44
Q2 20171$1.35$1.35$1.35
Q3 20171$1.24$1.24$1.24
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Walgreens Boots Alliance (NASDAQ:WBA)

Next Dividend:12/12/2017
Annual Dividend:$1.60
Dividend Yield:2.25%
Payout Ratio:42.33% (Trailing 12 Months of Earnings)
28.83% (Based on This Year's Estimates)
26.62% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Dividend History by Quarter for Walgreens Boots Alliance (NASDAQ WBA)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/25/2017quarterly$0.402.31%11/10/201711/13/201712/12/2017
7/13/2017quarterly$0.402.05%8/16/20178/18/20179/12/2017
4/21/2017quarterly$0.381.79%5/16/20175/18/20176/12/2017
1/27/2017quarterly$0.381.84%2/13/20172/15/20173/10/2017
10/13/2016quarterly$0.381.92%11/15/201611/17/201612/12/2016
7/14/2016quarterly$0.381.79%8/17/20168/19/20169/12/2016
4/13/2016quarterly$0.361.78%5/16/20165/18/20166/10/2016
1/29/2016quarterly$0.361.81%2/16/20162/18/20163/11/2016
10/15/2015quarterly$0.361.65%11/12/201511/16/201512/11/2015
7/10/2015quarterly$0.361.55%8/17/20158/19/20159/11/2015
4/9/2015quarterly$0.341.46%5/19/20155/21/20156/12/2015
1/16/2015special$0.342/13/20152/18/20153/12/2015
10/8/2014quarterly$0.342.19%11/13/201411/17/201412/12/2014
8/7/2014quarterly$0.342.22%8/19/20148/21/20149/12/2014
4/9/2014quarterly$0.321.99%5/19/20145/21/20146/12/2014
1/9/2014quarterly$0.322.09%2/13/20142/18/20143/12/2014
10/9/2013quarterly$0.322.25%11/14/201311/18/201312/12/2013
7/10/2013quarterly$0.322.59%8/16/20138/20/20139/12/2013
4/10/2013quarterly$0.282.26%5/17/20135/21/20136/12/2013
1/10/2013quarterly$0.282.81%2/13/20132/15/20133/12/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Walgreens Boots Alliance (NASDAQ WBA)

Insider Ownership Percentage: 13.50%
Institutional Ownership Percentage: 63.58%
Insider Trades by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)
Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Insider Trades by Quarter for Walgreens Boots Alliance (NASDAQ WBA)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/2/2017William C FooteDirectorSell2,736$67.37$184,324.32View SEC Filing  
10/26/2017John Anthony LedererDirectorBuy20,000$67.00$1,340,000.00View SEC Filing  
7/25/2017William C FooteDirectorSell2,736$79.79$218,305.44View SEC Filing  
5/3/2017William C FooteDirectorSell2,736$85.89$234,995.04View SEC Filing  
2/7/2017Ornella BarraCOOBuy124,000$80.93$10,035,320.00View SEC Filing  
2/2/2017Janice M BabiakDirectorBuy600$80.68$48,408.00View SEC Filing  
11/28/2016Kathleen Wilson-ThompsonEVPSell5,700$85.05$484,785.00View SEC Filing  
11/4/2016Stefano PessinaInsiderBuy2,000,000$81.41$162,820,000.00View SEC Filing  
11/2/2016William C FooteDirectorSell2,067$81.30$168,047.10View SEC Filing  
9/8/2016Kathleen Wilson-ThompsonEVPSell23,996$85.00$2,039,660.00View SEC Filing  
7/26/2016William C FooteDirectorSell2,067$81.35$168,150.45View SEC Filing  
7/14/2016Kathleen Wilson-ThompsonEVPSell29,695$83.00$2,464,685.00View SEC Filing  
7/8/2016Kathleen Wilson-ThompsonEVPSell29,695$81.03$2,406,185.85View SEC Filing  
6/10/2016Kathleen Wilson-ThompsonEVPSell29,603$83.13$2,460,897.39View SEC Filing  
5/16/2016Barry RosensteinDirectorSell6,000,000$77.29$463,740,000.00View SEC Filing  
4/21/2016William C FooteDirectorSell2,066$80.99$167,325.34View SEC Filing  
4/15/2016George Rollo FairweatherCFOSell50,000$81.52$4,076,000.00View SEC Filing  
3/17/2016Kathleen Wilson-ThompsonEVPSell13,728$83.01$1,139,561.28View SEC Filing  
2/18/2016Barry RosensteinDirectorSell1,720,900$76.96$132,440,464.00View SEC Filing  
1/12/2016John Anthony LedererDirectorBuy10,000$81.00$810,000.00View SEC Filing  
11/20/2015Barry RosensteinDirectorSell1,452,470$82.37$119,639,953.90View SEC Filing  
11/4/2015William C FooteDirectorSell3,500$88.36$309,260.00View SEC Filing  
11/2/2015John Anthony LedererDirectorBuy10,000$84.88$848,800.00View SEC Filing  
7/16/2015William C FooteDirectorSell3,500$94.95$332,325.00View SEC Filing  
4/29/2015John Anthony LedererDirectorBuy10,000$85.00$850,000.00View SEC Filing  
1/29/2015Thomas J Sabatino JrCAOSell36,477$73.76$2,690,543.52View SEC Filing  
12/15/2014Kathleen Wilson-ThompsonSVPSell40,769$73.75$3,006,713.75View SEC Filing  
11/7/2014Kermit R CrawfordEVPSell126,441$66.32$8,385,567.12View SEC Filing  
11/3/2014Sona ChawlaCMOSell21,200$65.00$1,378,000.00View SEC Filing  
10/14/2014Barry RosensteinDirectorBuy1,250,000$61.86$77,325,000.00View SEC Filing  
9/19/2014Sona ChawlaCMOSell9,443$63.44$599,063.92View SEC Filing  
8/11/2014Mia M ScholzSVPSell81,015$61.93$5,017,258.95View SEC Filing  
8/7/2014Gregory D WassonCEOSell24,279$60.06$1,458,196.74View SEC Filing  
4/16/2014Robert ZimmermanSVPSell26,201$66.07$1,731,100.07View SEC Filing  
4/15/2014Kermit CrawfordInsiderSell74,287$66.01$4,903,684.87View SEC Filing  
1/24/2014Graham AtkinsonSVPSell24,304$58.05$1,410,847.20View SEC Filing  
1/16/2014Robert ZimmermanSVPSell10,426$60.00$625,560.00View SEC Filing  
1/13/2014Timothy TheriaultSVPSell64,815$60.50$3,921,307.50View SEC Filing  
7/12/2013Stefano PessinaDirectorBuy34,439$45.77$1,576,273.03View SEC Filing  
5/21/2013Kermit R CrawfordInsiderSell10,000$50.03$500,300.00View SEC Filing  
4/19/2013Stefano PessinaDirectorBuy83,299$48.62$4,049,997.38View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Walgreens Boots Alliance (NASDAQ:WBA)

Latest Headlines for Walgreens Boots Alliance (NASDAQ WBA)

Source:
DateHeadline
Walgreens Boots Alliance (WBA) versus Cardinal Health (CAH) Head-To-Head ContrastWalgreens Boots Alliance (WBA) versus Cardinal Health (CAH) Head-To-Head Contrast
www.americanbankingnews.com - November 15 at 9:34 PM
Critical Analysis: CVS Health Corporation (CVS) and Walgreens Boots Alliance (WBA)Critical Analysis: CVS Health Corporation (CVS) and Walgreens Boots Alliance (WBA)
www.americanbankingnews.com - November 14 at 3:10 AM
Walgreens Boots Alliance - Fairly Valued Dividend Aristocrat - Seeking AlphaWalgreens Boots Alliance - Fairly Valued Dividend Aristocrat - Seeking Alpha
seekingalpha.com - November 13 at 5:55 PM
Comparing Walgreens Boots Alliance (WBA) and CVS Health Corporation (CVS)Comparing Walgreens Boots Alliance (WBA) and CVS Health Corporation (CVS)
www.americanbankingnews.com - November 12 at 11:54 PM
Walgreens Isnt Out of the Weeds Yet Even After Earnings BeatWalgreens Isn't Out of the Weeds Yet Even After Earnings Beat
www.thestreet.com - November 12 at 1:19 PM
 Brokerages Anticipate Walgreens Boots Alliance, Inc. (WBA) to Post $1.26 EPS Brokerages Anticipate Walgreens Boots Alliance, Inc. (WBA) to Post $1.26 EPS
www.americanbankingnews.com - November 10 at 3:38 AM
Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for November 10, 2017 - NasdaqWalgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for November 10, 2017 - Nasdaq
www.nasdaq.com - November 9 at 9:50 AM
Walgreens Boots Alliance (WBA) & McKesson Corporation (MCK) Financial AnalysisWalgreens Boots Alliance (WBA) & McKesson Corporation (MCK) Financial Analysis
www.americanbankingnews.com - November 9 at 3:10 AM
Negative Industry Group Rank Keep Walgreens Boots Alliance (WBA) a Strong Sell - Investorplace.comNegative Industry Group Rank Keep Walgreens Boots Alliance (WBA) a Strong Sell - Investorplace.com
investorplace.com - November 7 at 11:34 PM
After tumultuous year, Freds stock hit 52-week lowAfter tumultuous year, Fred's stock hit 52-week low
finance.yahoo.com - November 7 at 6:33 PM
Walgreens Honors Veterans, Active Duty Military and Families with Veterans Day Discount Saturday, Nov. 11Walgreens Honors Veterans, Active Duty Military and Families with Veterans Day Discount Saturday, Nov. 11
finance.yahoo.com - November 7 at 1:28 PM
Walgreens Boots Alliance, Inc. (WBA) Receives Consensus Rating of "Buy" from BrokeragesWalgreens Boots Alliance, Inc. (WBA) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 6 at 8:28 PM
Negative Industry Group Rank Keep Walgreens Boots Alliance (WBA) a Strong SellNegative Industry Group Rank Keep Walgreens Boots Alliance (WBA) a Strong Sell
investorplace.com - November 6 at 5:09 PM
States Focus On Incentives Of Wholesalers and Pharmacies In Drug Price-Fixing ProbeStates Focus On Incentives Of Wholesalers and Pharmacies In Drug Price-Fixing Probe
finance.yahoo.com - November 6 at 9:07 AM
Walgreens opening in South Natomas, but not for a whileWalgreens opening in South Natomas, but not for a while
finance.yahoo.com - November 4 at 6:22 AM
Insider Selling: Walgreens Boots Alliance, Inc. (WBA) Director Sells 2,736 Shares of StockInsider Selling: Walgreens Boots Alliance, Inc. (WBA) Director Sells 2,736 Shares of Stock
www.americanbankingnews.com - November 3 at 9:00 PM
Amazon, CVS to Nab Walgreen’s Rx Business: LeerinkAmazon, CVS to Nab Walgreen’s Rx Business: Leerink
finance.yahoo.com - November 3 at 9:41 AM
Uh Oh, Walgreens. Amazons Pharmacy Is Getting Closer to RealityUh Oh, Walgreens. Amazon's Pharmacy Is Getting Closer to Reality
finance.yahoo.com - November 2 at 9:09 PM
AmerisourceBergen (ABC) Beats Q4 Earnings, Issues FY18 ViewAmerisourceBergen (ABC) Beats Q4 Earnings, Issues FY18 View
finance.yahoo.com - November 2 at 11:22 AM
Walgreens Boots Alliance, Inc. (WBA) Given New $81.00 Price Target at Citigroup Inc.Walgreens Boots Alliance, Inc. (WBA) Given New $81.00 Price Target at Citigroup Inc.
www.americanbankingnews.com - November 2 at 9:10 AM
Walgreens Boots Alliance, Inc. (WBA) Downgraded by Leerink Swann to Market PerformWalgreens Boots Alliance, Inc. (WBA) Downgraded by Leerink Swann to Market Perform
www.americanbankingnews.com - November 1 at 11:11 AM
Walgreens Better Watch Its Back With Amazon Lurking - TheStreet.comWalgreens Better Watch Its Back With Amazon Lurking - TheStreet.com
www.thestreet.com - November 1 at 10:38 AM
Thank You Amazon For Putting Walgreens On Sale - Seeking AlphaThank You Amazon For Putting Walgreens On Sale - Seeking Alpha
seekingalpha.com - November 1 at 10:38 AM
Is The Plunge Of Walgreens Boots Alliance To A 3-Year Low Justified? - Seeking AlphaIs The Plunge Of Walgreens Boots Alliance To A 3-Year Low Justified? - Seeking Alpha
seekingalpha.com - November 1 at 10:38 AM
CVS Health’s Stock Hits a Multi-Year Low: Here’s WhyCVS Health’s Stock Hits a Multi-Year Low: Here’s Why
finance.yahoo.com - November 1 at 10:38 AM
Walgreens Better Watch Its Back With Amazon LurkingWalgreens Better Watch Its Back With Amazon Lurking
finance.yahoo.com - November 1 at 10:38 AM
Walgreens: Strong 4Q17 Results Support the Falling Stock PriceWalgreens: Strong 4Q17 Results Support the Falling Stock Price
finance.yahoo.com - October 31 at 12:06 PM
ETFs with exposure to Walgreens Boots Alliance, Inc. : October 30, 2017ETFs with exposure to Walgreens Boots Alliance, Inc. : October 30, 2017
finance.yahoo.com - October 31 at 12:06 PM
Walgreens Boots Alliance Completes Long-Term Global Supply Agreement with FarevaWalgreens Boots Alliance Completes Long-Term Global Supply Agreement with Fareva
finance.yahoo.com - October 31 at 12:06 PM
The Zacks Analyst Blog Highlights: JPMorgan Chase, Gilead, ConocoPhillips, General Electric and WalgreensThe Zacks Analyst Blog Highlights: JPMorgan Chase, Gilead, ConocoPhillips, General Electric and Walgreens
finance.yahoo.com - October 31 at 12:06 PM
Walgreens Boots Alliance, Inc. (WBA) Director Buys $1,340,000.00 in StockWalgreens Boots Alliance, Inc. (WBA) Director Buys $1,340,000.00 in Stock
www.americanbankingnews.com - October 30 at 8:36 AM
Walgreens Boots Alliance Looks Very Cheap HereWalgreens Boots Alliance Looks Very Cheap Here
seekingalpha.com - October 28 at 8:45 AM
Amazon Threat Subsides As Walgreens, CVS Bolster Networks, DistributionAmazon Threat Subsides As Walgreens, CVS Bolster Networks, Distribution
finance.yahoo.com - October 28 at 8:44 AM
Walgreens Boots Alliance, Inc. :WBA-US: Earnings Analysis: Q4, 2017 By the Numbers : October 27, 2017Walgreens Boots Alliance, Inc. :WBA-US: Earnings Analysis: Q4, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 28 at 8:44 AM
Walgreens Tops Sales and Earnings Expectations in 4Q17Walgreens Tops Sales and Earnings Expectations in 4Q17
finance.yahoo.com - October 28 at 8:44 AM
What Drove Walgreens’ 4Q17 Top Line?What Drove Walgreens’ 4Q17 Top Line?
finance.yahoo.com - October 28 at 8:44 AM
Amazon and Alphabet break through the $1,000 barrierAmazon and Alphabet break through the $1,000 barrier
finance.yahoo.com - October 28 at 8:44 AM
Walgreens: Strong US Pharmacy SalesWalgreens: Strong US Pharmacy Sales
finance.yahoo.com - October 28 at 8:44 AM
CVS is under pressure in their retail pharmacy business: ...CVS is under pressure in their retail pharmacy business: ...
finance.yahoo.com - October 28 at 8:44 AM
Analyzing Walgreens’ 4Q17 Earnings BeatAnalyzing Walgreens’ 4Q17 Earnings Beat
finance.yahoo.com - October 28 at 8:44 AM
Walgreens Boots Alliance, Inc. (WBA) Issues Quarterly  Earnings ResultsWalgreens Boots Alliance, Inc. (WBA) Issues Quarterly Earnings Results
www.americanbankingnews.com - October 26 at 4:50 PM
Walgreens Boots Alliance, Inc. (WBA) PT Set at $90.00 by Loop CapitalWalgreens Boots Alliance, Inc. (WBA) PT Set at $90.00 by Loop Capital
www.americanbankingnews.com - October 26 at 1:34 PM
Share Buyback Program Declared by Walgreens Boots Alliance (WBA) Share Buyback Program Declared by Walgreens Boots Alliance (WBA)
www.americanbankingnews.com - October 26 at 11:34 AM
Walgreens Boots Alliance, Inc. to Issue Quarterly Dividend of $0.40 (WBA)Walgreens Boots Alliance, Inc. to Issue Quarterly Dividend of $0.40 (WBA)
www.americanbankingnews.com - October 26 at 9:56 AM
Royal Bank Of Canada Reaffirms "Buy" Rating for Walgreens Boots Alliance, Inc. (WBA)Royal Bank Of Canada Reaffirms "Buy" Rating for Walgreens Boots Alliance, Inc. (WBA)
www.americanbankingnews.com - October 25 at 11:08 PM
Walgreens Boots Alliance Inc (WBA) Earnings: 9 Things to Know About Q4Walgreens Boots Alliance Inc (WBA) Earnings: 9 Things to Know About Q4
investorplace.com - October 25 at 2:01 PM
Walgreens Boots Alliance, Inc. (WBA) Releases FY18 Earnings GuidanceWalgreens Boots Alliance, Inc. (WBA) Releases FY18 Earnings Guidance
www.americanbankingnews.com - October 25 at 9:50 AM
Walgreens Boots Alliance Declares Regular Quarterly Dividend - Business Wire (press release)Walgreens Boots Alliance Declares Regular Quarterly Dividend - Business Wire (press release)
www.businesswire.com - October 25 at 2:38 AM
Walgreens Boots Alliances (WBA) "Buy" Rating Reiterated at MizuhoWalgreens Boots Alliance's (WBA) "Buy" Rating Reiterated at Mizuho
www.americanbankingnews.com - October 24 at 9:58 PM
Walgreens Boots Alliance Declares Regular Quarterly DividendWalgreens Boots Alliance Declares Regular Quarterly Dividend
finance.yahoo.com - October 24 at 9:37 PM

Social Media

Financials

Chart

Walgreens Boots Alliance (NASDAQ WBA) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.